Live feed
Filing
SC 13G/A
SC 13G/A0000919574-19-000684·Citius Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
CITIUS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 17322U207
Event date: 2018-12-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 4.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-19-000684
- Form type
- SC 13G/A
- Filer
- Citius Pharmaceuticals, Inc.
- CIK
- CIK 1506251
- Filed
- Jan 30, 2019
- Reporting period
- Dec 30, 2018
- Description
- Schedule 13G beneficial ownership